Paxman AB (publ) (PAX.ST)
SEK 65.0
(0.0%)
SEK 65.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 19.99 Million SEK | -26.37% |
| 2022 | 27.16 Million SEK | 49.97% |
| 2021 | 18.11 Million SEK | 31.75% |
| 2020 | 13.74 Million SEK | 15.89% |
| 2019 | 11.86 Million SEK | 51.69% |
| 2018 | 7.81 Million SEK | -8.52% |
| 2017 | 8.54 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 23.39 Million SEK | 16.99% |
| 2024 Q2 | 24.74 Million SEK | 5.78% |
| 2023 Q4 | 19.99 Million SEK | -12.18% |
| 2023 Q3 | 22.77 Million SEK | -15.67% |
| 2023 FY | 19.99 Million SEK | -26.37% |
| 2023 Q1 | 28.63 Million SEK | 5.42% |
| 2023 Q2 | 27 Million SEK | -5.69% |
| 2022 Q3 | 23.64 Million SEK | 22.07% |
| 2022 FY | 27.16 Million SEK | 49.97% |
| 2022 Q1 | 19.2 Million SEK | 6.04% |
| 2022 Q4 | 27.16 Million SEK | 14.88% |
| 2022 Q2 | 19.36 Million SEK | 0.86% |
| 2021 Q3 | 16.86 Million SEK | 13.62% |
| 2021 Q4 | 18.11 Million SEK | 7.36% |
| 2021 FY | 18.11 Million SEK | 31.75% |
| 2021 Q1 | 14.5 Million SEK | 5.55% |
| 2021 Q2 | 14.84 Million SEK | 2.33% |
| 2020 FY | 13.74 Million SEK | 15.89% |
| 2020 Q3 | 14.83 Million SEK | 2.65% |
| 2020 Q4 | 13.74 Million SEK | -7.33% |
| 2020 Q2 | 14.45 Million SEK | -0.78% |
| 2020 Q1 | 14.56 Million SEK | 22.8% |
| 2019 Q4 | 11.86 Million SEK | 17.62% |
| 2019 Q3 | 10.08 Million SEK | -2.27% |
| 2019 Q1 | 9.94 Million SEK | 27.14% |
| 2019 FY | 11.86 Million SEK | 51.69% |
| 2019 Q2 | 10.31 Million SEK | 3.79% |
| 2018 Q3 | 9.82 Million SEK | 4.85% |
| 2018 FY | 7.81 Million SEK | -8.52% |
| 2018 Q1 | 9.7 Million SEK | 13.54% |
| 2018 Q4 | 7.81 Million SEK | -20.41% |
| 2018 Q2 | 9.37 Million SEK | -3.44% |
| 2017 FY | 8.54 Million SEK | 0.0% |
| 2017 Q2 | 6.02 Million SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2017 Q4 | 8.54 Million SEK | 19.47% |
| 2017 Q3 | 7.15 Million SEK | 18.68% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | -192.426% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 83.499% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 83.499% |
| Arcoma AB | 28.02 Million SEK | 28.644% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | 32.541% |
| BICO Group AB (publ) | 493.1 Million SEK | 95.944% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | 67.95% |
| CellaVision AB (publ) | 126.03 Million SEK | 84.133% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -227.048% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -1029.299% |
| C-Rad AB (publ) | 64.09 Million SEK | 68.8% |
| Duearity AB (publ) | 4.15 Million SEK | -380.861% |
| Dignitana AB (publ) | 7.41 Million SEK | -169.783% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -440.514% |
| Getinge AB (publ) | 6.41 Billion SEK | 99.688% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 1288.033% |
| Iconovo AB (publ) | -4.86 Million SEK | 511.333% |
| Integrum AB (publ) | 22.36 Million SEK | 10.567% |
| Luxbright AB (publ) | 8000.00 SEK | -249887.5% |
| Mentice AB (publ) | 14.1 Million SEK | -41.797% |
| OssDsign AB (publ) | 4.3 Million SEK | -364.661% |
| Promimic AB (publ) | 330 Thousand SEK | -5960.303% |
| Qlife Holding AB (publ) | 7.29 Million SEK | -174.259% |
| SciBase Holding AB (publ) | 11.91 Million SEK | -67.791% |
| ScandiDos AB (publ) | 22.69 Million SEK | 11.86% |
| Sectra AB (publ) | 36.59 Million SEK | 45.343% |
| Sedana Medical AB (publ) | 42.97 Million SEK | 53.464% |
| Senzime AB (publ) | 20.34 Million SEK | 1.676% |
| SpectraCure AB (publ) | 1.00 SEK | -1999899900.0% |
| Stille AB | 66.55 Million SEK | 69.95% |
| Vitrolife AB (publ) | 413 Million SEK | 95.158% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 85.877% |